EC Healthcare provides medical and healthcare services in Hong Kong, Macau, Mainland China, and Taiwan. It operates through Medical; Aesthetic Medical and Beauty and Wellness; and Veterinary and Other segments. The company offers health checkups and screening, vaccinations, laboratory testing, imaging diagnostics, dental care, and pain management services; quasi-medical and chiropractic services; and aesthetic medical, beauty, haircare, and wellness services. It also provides general and family medicine, musculoskeletal health, eye care, fertility and women’s health, men’s and children’s health, digestive health, chronic disease management, Chinese and sports medicine, corporate medicine and work rehabilitation, preventive screening, rehabilitation and homecare, heart and vascular health, oncology and cancer, and allergies and immunology services. In addition, the company operates veterinary hospitals and clinics that provide medical and surgical procedures, health checks, blood tests, 24-hour emergency and inpatient, computer scanning, endoscopy, and isolation wards, etc.; offers cosmetics; leases and distributes aesthetic devices; owns trademarks; and sells skincare, healthcare, and beauty products. Further, it engages in property investment; healthcare machine operation; beauty brand management and cosmetic business development; administrative, management, and marketing; electric vehicle charging infrastructure; scientific instruments; lifestyle enhancement; audio engineering and acoustic technology; intelligent transportation systems; multi-channel networking; biotechnology, life sciences, genomic data, and molecular diagnostics; and travel agency services. It offers its products and services under the PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH brands. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Quarry Bay, Hong Kong.
Metrics to compare | 2138 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship2138PeersSector | |
---|---|---|---|---|
P/E Ratio | −4.7x | −2.6x | 11.2x | |
PEG Ratio | 0.01 | −0.19 | 0.02 | |
Price/Book | 0.4x | 0.5x | 1.4x | |
Price / LTM Sales | 0.2x | 1.2x | 1.0x | |
Upside (Analyst Target) | 223.1% | 51.8% | 20.3% | |
Fair Value Upside | Unlock | 0.4% | 8.7% | Unlock |